Johnson & Johnson leads globally in healthcare stocks, with a market capitalization of approximately $390 billion. Despite a 76% rise over the past decade, the company's growth has been lackluster, prompting a strategic shift towards areas with growth potential.
One strategy for healthcare companies to expand their operations is through internal development and acquisitions. Johnson & Johnson is actively pursuing both avenues, with involvement in various clinical trials and recent acquisitions in the medical device and pharmaceutical sectors.
[
add
]
[
|
|
...
]